Skip to content
Stop using now Drug recall · FDA · Published September 6, 2013

Recall: CVS, Equate, Up & Up Lubricant Eye Drops Mold Risk

CVS Pharmacy, Equate, and Up & Up lubricant eye drops recalled due to non-sterility. Mold may grow after opening because the preservative may not be effective.

🇺🇸 FDA recall #D-375-2014DrugCVS / Equate / Up & Up ›
Take action

Contact the company

Recalling firmAltaire Pharmaceuticals, Inc.311 West Lane, P.O. Box 849 · Aquebogue, NY 11931-0849
✎ GovInfoNow plain-language explainer

Altaire Pharmaceuticals is recalling specific lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution sold under the CVS Pharmacy, Equate, and Up & Up brands. The issue is that the preservative in these bottles may not remain effective through the expiration date, allowing mold to grow after the product is opened. This affects approximately 363,746 bottles distributed nationwide. Read more at govinfonow.com/recall/46633-altaire-pharmaceuticals-inc-recalls-carboxymethylcellulose-sodium-0-5-ophthalmic-solution.

Source Summary by GovInfoNow · govinfonow.com/recall/46633-altaire-pharmaceuticals-inc-recalls-carboxymethylcellulose-sodium-0-5-ophthalmic-solution · Updated October 13, 2026 · FDA enforcement record: FDA #D-375-2014

Cite this page

“Recall: CVS, Equate, Up & Up Lubricant Eye Drops Mold Risk.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46633-altaire-pharmaceuticals-inc-recalls-carboxymethylcellulose-sodium-0-5-ophthalmic-solution. Based on FDA recall #D-375-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-375-2014%22&limit=1).

The FDA announced on 2013-09-06 that Altaire Pharmaceuticals, Inc. voluntarily recalled Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution due to non-sterility risks. The agency stated the preservative may not remain effective through expiry, potentially allowing mold growth.

How to tell if you have it

  • CVS pharmacy brand LUBRICANT EYE DROPS FOR MILD TO MODERATE DRY EYE
  • equate brand Lubricant Eye Drops
  • up & up brand lubricant eye drops
  • 1 FL OZ (30 mL) bottle
  • UPC 0 50428 053357 7
  • UPC 0 50428 27364 7
  • UPC 6 81131 03420 3
  • UPC 8 58961 79102 0
  • Lot #11440, Exp 09/13
  • Lot #11441, Exp 09/13
  • Lot #12042, Exp 01/14
  • Lot #12103, Exp 02/15
  • Lot #12203, Exp 05/15
  • Lot #12207, Exp 05/15
  • Lot #12293, Exp 08/15
  • Lot #12352, Exp 09/15
  • Lot #12356, Exp 09/15

The hazard

The FDA reported that customer complaints of mold in the product after use and handling were linked to the preservative in the lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution potentially not being effective through expiry.

Context

GovInfoNow's records show Altaire Pharmaceuticals, Inc. has one other recall on record since 2019-07-02. On 2019-07-02, the company issued a Walgreens Eye Drops Recall citing a risk of contaminated solution due to lack of assurance of sterility. Other recent recalls of similar products include Sterile Lubricant Dry Eye Relief Eye Drops (2026-09-11), K.C. Pharmaceuticals Recalls Sterile Eye Drops Due to Lack of Sterility Assurance (2026-03-03), and K.C. Pharmaceuticals Recalls Eye Drops Due to Lack of Sterility Assurance (2026-03-03).

How to tell if you have this one

Check your eye drop bottle for the brand name (CVS Pharmacy Lubricant Eye Drops, Equate Lubricant Eye Drops, or Up & Up Lubricant Eye Drops) and the lot number on the label. Affected lots include 11440, 11441, 12042, 12103, 12203, 12207, 12293, 12352, and 12356. Verify the expiration date matches the lot (e.g., Exp 09/13 for lots 11440/11441).

  • Brand
    CVS / Equate / Up & Up
  • Product
    Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution, 1 FL OZ (30 mL) bottle, sold under the following labels: (a)
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the eye drops

    Do not use any eye drops from the recalled lots because they may contain mold.

  2. Discard or return the product

    The record does not specify a remedy, so you should dispose of the product safely or contact the retailer for guidance.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Sep 6, 201312. FDA classified it Class I: Dec 18, 201323. Published in FDA’s Enforcement Report: Dec 25, 201334. FDA terminated the recall: Sep 30, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-375-2014 (September 6, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-375-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA